NasdaqCM - Nasdaq Real Time Price
USD
Zhengye Biotechnology Holding Limited (ZYBT)
2.3600
+1.0800
(+84.38%)
At close: August 5 at 4:00:01 PM EDT
1.7400
-0.6200
(-26.27%)
Overnight: 9:53:55 PM EDT
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Loading chart for ZYBT
Chart does not reflect overnight price.
- Previous Close
1.2800 - Open
1.2800 - Bid 0.9648 x 200
- Ask 1.6200 x 200
- Day's Range
1.2600 - 4.2900 - 52 Week Range
0.6160 - 13.0800 - Volume
71,019,351 - Avg. Volume
3,929,044 - Market Cap (intraday)
111.844M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View More
Performance Overview
Trailing total returns as of 8/5/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
ZYBT
105.22%
S&P 500 (^GSPC)
12.83%
1-Year Return
ZYBT
58.96%
S&P 500 (^GSPC)
22.61%
3-Year Return
ZYBT
37.40%
S&P 500 (^GSPC)
72.48%
5-Year Return
ZYBT
37.40%
S&P 500 (^GSPC)
74.38%
Statistics
View MoreValuation Measures
As of 7/31/2026
-
Market Cap
62.56M
-
Enterprise Value
65.98M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
3.63
-
Price/Book (mrq)
1.69
-
Enterprise Value/Revenue
3.84
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-59.97%
-
Return on Assets (ttm)
-9.48%
-
Return on Equity (ttm)
-25.17%
-
Revenue (ttm)
116.36M
-
Net Income Avi to Common (ttm)
-69.78M
-
Diluted EPS (ttm)
-0.2200
Balance Sheet and Cash Flow
-
Total Cash (mrq)
51.89M
-
Total Debt/Equity (mrq)
24.48%
-
Levered Free Cash Flow (ttm)
39.58M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
2.3600
+84.38%
Mkt Cap
111.844M
Industry
Drug Manufacturers—Specialty & Generic
0.0001
0.00%
Mkt Cap
722,675
Industry
Drug Manufacturers—Specialty & Generic
16.370
-0.85%
Mkt Cap
HKD
43.715B
Industry
Drug Manufacturers—Specialty & Generic
1.2600
+6.78%
Mkt Cap
51.058M
Industry
Drug Manufacturers—Specialty & Generic
1.5600
0.00%
Mkt Cap
14.183M
Industry
Drug Manufacturers—Specialty & Generic
36.01
-1.59%
Mkt Cap
1.461B
Industry
Drug Manufacturers—Specialty & Generic
10,430.00
+0.77%
Mkt Cap
ILA
121.54B
Industry
Drug Manufacturers—Specialty & Generic
0.0670
-45.57%
Mkt Cap
2.561M
Industry
Drug Manufacturers—Specialty & Generic
1.2900
-2.27%
Mkt Cap
346.053M
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
